Lv1
42 积分 2023-07-24 加入
Redefining First-Line HER2-Positive Advanced Gastric Cancer: From Trastuzumab-Based Chemoimmunotherapy to Zanidatamab and Next-Generation HER2 Targeting
1个月前
已完结
Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review
2个月前
已完结
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practice
2个月前
已完结
Immune-Related Adverse Events From Checkpoint Inhibitors: An Evidence-Based Management Review
3个月前
已完结
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practice
3个月前
已完结
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer
4个月前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
4个月前
已完结
Emerging trends in the global burden of colorectal cancer
4个月前
已完结
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649
4个月前
已完结
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
4个月前
已完结
皖公网安备34019202002308
